您的位置: 首页 > 农业专利 > 详情页

INHIBITEURS MACROCYCLIQUES DE LA KINASE LRRK2
专利权人:
IPSEN PHARMA S.A.S.;ONCODESIGN S.A.
发明人:
HOFLACK, JAN,BLOM, PETRA
申请号:
CA2850350
公开号:
CA2850350A1
申请日:
2012.09.28
申请国别(地区):
CA
年份:
2013
代理人:
摘要:
The present invention relates to novel macrocylic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of LRRK2 (Leucine-Rich Repeat Kinase 2). Moreover, the present invention provides processes for the preparation of the disclosed compounds, as well as methods of using them, for instance as a medicine or diagnostic agent, in particular for the treatment and/or diagnosis of diseases characterized by LRRK2 kinase activity such as neurological disorders including Parkinson's disease and Alzheimer's disease.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充